17β-estradiol ameliorates tight junction disruption via repression of MMP transcription

Molecular Endocrinology

Volumn 29, Issue 9, 2015, Pages 1347-1361

  Na, Wonho ^a   Lee, Jee Youn ^b   Kim, Won Sun ^a   Yune, Tae Young ^b   Ju, Bong Gun ^a  

^a Sogang University   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; ESTRADIOL; FREE RADICAL; FULVESTRANT; GELATINASE A; GELATINASE B; GLUCOSE; INTERSTITIAL COLLAGENASE; NUCLEAR RECEPTOR COREPRESSOR; OXYGEN; STROMELYSIN; STROMELYSIN 2; TIGHT JUNCTION PROTEIN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ANTAGONIST; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIX METALLOPROTEINASE; SMALL INTERFERING RNA;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY ENDOTHELIAL CELL; BRAIN INJURY; BRAIN PROTECTION; CONTROLLED STUDY; GENE ACTIVATION; GENE REPRESSION; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPERFUSION INJURY; SPINAL CORD; SPINAL CORD INJURY; TIGHT JUNCTION; UPREGULATION; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL LINE; CYTOLOGY; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENETICS; IMPEDANCE; METABOLISM; PATHOLOGY; RAT; RNA INTERFERENCE; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN INJURIES; CELL LINE; ELECTRIC IMPEDANCE; ENDOTHELIAL CELLS; ENZYME ACTIVATION; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ANTAGONISTS; MALE; MATRIX METALLOPROTEINASES; MICE; NF-KAPPA B; PROMOTER REGIONS, GENETIC; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; RNA INTERFERENCE; RNA, SMALL INTERFERING; TIGHT JUNCTIONS;

EID: 84940752501     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/ME.2015-1124     Document Type: Article

References (83)

1. Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev. 2005;57:173–185
2. Bartanusz V, Jezova D, Alajajian B, Digicaylioglu M. The bloodspinal cord barrier: morphology and clinical implications. Ann Neurol. 2011;70:194–206
3. Haseloff RF, Dithmer S, Winkler L, Wolburg H, Blasig IE. Transmembrane proteins of the tight junctions at the blood-brain barrier: Structural and functional aspects. Semin Cell Dev Biol. 2014;38: 16–25
4. Stamatovic SM, Keep RF, Andjelkovic AV. Brain endothelial cellcell junctions: how to “open” the blood brain barrier. Curr Neuropharmacol. 2008;6:179–192
5. Drewes LR. Molecular architecture of the brain microvasculature: perspective on blood-brain transport. J Mol Neurosci. 2001;16:93–98
6. Yang Y, Rosenberg GA. Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke. 2011;42:3323–3328
7. Romero IA, Radewicz K, Jubin E, et al. Changes in cytoskeletal and tight junctional proteins correlate with decreased permeability induced by dexamethasone in cultured rat brain endothelial cells. Neurosci Lett. 2003;344:112–116
8. Förster C, Silwedel C, Golenhofen N, et al. Occludin as direct target for glucocorticoid-induced improvement of blood-brain barrier properties in a murine in vitro system. J Physiol. 2005;565:475–486
9. Paul C, Bolton C. Inhibition of blood-brain barrier disruption in experimental allergic encephalomyelitis by short-term therapy with dexamethasone or cyclosporin A. Int J Immunopharmacol. 1995; 17:497–503
10. Kleinschnitz C, Blecharz K, Kahles T, et al. Glucocorticoid insensitivity at the hypoxic blood-brain barrier can be reversed by inhibition of the proteasome. Stroke. 2011;42:1081–1089
11. Pascual JL, Murcy MA, Li S, et al. Neuroprotective effects of progesterone in traumatic brain injury: blunted in vivo neutrophil activation at the blood-brain barrier. Am J Surg. 2013;206:840–845
12. Chi OZ, Liu X, Weiss HR. Effects of 17b-estradiol on blood-brain barrier disruption during focal ischemia in rats. Horm Metab Res. 2002;34:530–534
13. Liu R, Wen Y, Perez E, et al. 17b-Estradiol attenuates blood-brain barrier disruption induced by cerebral ischemia-reperfusion injury in female rats. Brain Res. 2005;1060:55–61
14. Lee JY, Choi HY, Na WH, Ju BG, Yune TY. 17b-Estradiol inhibits MMP-9 and SUR1/TrpM4 expression and activation and thereby attenuates BSCB disruption/hemorrhage after spinal cord injury in male rats. Endocrinology. 2015;156:1838–1850
15. Asl SZ, Khaksari M, Khachki AS, Shahrokhi N, Nourizade S. Contribution of estrogen receptors a and b in the brain response to traumatic brain injury. J Neurosurg. 2013;119:353–361
16. Shin JA, Yang SJ, Jeong SI, et al. Activation of estrogen receptor reduces blood-brain barrier breakdown following ischemic injury. Neuroscience. 2013;235:165–173
17. Sun X, Ji C, Hu T, Wang Z, Chen G. Tamoxifen as an effective neuroprotectant against early brain injury and learning deficits induced by subarachnoid hemorrhage: possible involvement of inflammatory signaling. J Neuroinflammation. 2013;10:157
18. Li M, Zhang Z, Sun W, Koehler RC, Huang J. 17b-Estradiol attenuates breakdown of blood-brain barrier and hemorrhagic transformation induced by tissue plasminogen activator in cerebral ischemia. Neurobiol Dis. 2011;44:277–283
19. Lu T, Achari Y, Sciore P, Hart DA. Estrogen receptor b regulates matrix metalloproteinase-13 promoter activity primarily through the AP-1 transcriptional regulatory site. Biochim Biophys Acta. 2006;1762:719–731
20. Scafonas A, Reszka AA, Kimmel DB, et al. Agonist-like SERM effects on ERb-mediated repression of MMP1 promoter activity predict in vivo effects on bone and uterus. J Steroid Biochem Mol Biol. 2008;110:197–206
21. Mahmoodzadeh S, Dworatzek E, Fritschka S, Pham TH, Regitz- Zagrosek V. 17b-Estradiol inhibits matrix metalloproteinase-2 transcription via MAP kinase in fibroblasts. Cardiovasc Res. 2010; 85:719–728
22. Burek M, Steinberg K, Förster CY. Mechanisms of transcriptional activation of the mouse claudin-5 promoter by estrogen receptor a and b. Mol Cell Endocrinol. 2014;392:144–151
23. Dimitrijevic OB, Stamatovic SM, Keep RF, Andjelkovic AV. Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion injury. J Cereb Blood Flow Metab. 2006;26: 797–810
24. Narasimhan P, Liu J, Song YS, Massengale JL, Chan PH. VEGF Stimulates the ERK 1/2 signaling pathway and apoptosis in cerebral endothelial cells after ischemic conditions. Stroke. 2009;40:1467–1473
25. Guo J, Krause DN, Horne J, et al. Estrogen-receptor-mediated protection of cerebral endothelial cell viability and mitochondrial function after ischemic insult in vitro. J Cereb Blood Flow Metab. 2010; 30:545–554
26. Lee K, Na W, Lee JY, et al. Molecular mechanism of Jmjd3-mediated interleukin-6 gene regulation in endothelial cells underlying spinal cord injury. J Neurochem. 2012;122:272–282
27. Yune TY, Lee JY, Jung GY, et al. Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury. J Neurosci. 2007;27:7751–7761
28. Lee JY, Choi SY, OH TH, Yune TY. 17b-Estradiol inhibits apoptotic cell death of oligodendrocytes by inhibiting RhoA-JNK3 activation after spinal cord injury. Endocrinology. 2012;153:3815–3827
29. He F, Peng J, Deng XL, et al. RhoA and NF-kB are involved in lipopolysaccharide-induced brain microvascular cell line hyperpermeability. Neuroscience. 2011;188:35–47
30. Welboren WJ, van Driel MA, Janssen-Megens EM, et al. ChIP-Seq of ERb and RNApolymerase II defines genes differentially responding to ligands. EMBO J. 2009;28:1418–1428
31. Hewitt SC, Li L, Grimm SA, et al. Research resource: whole-gedoi nome estrogen receptor binding in mouse uterine tissue revealed by ChIP-seq. Mol Endocrinol. 2012;26:887–898
32. Carroll JS, Meyer CA, Song J, et al. Genome-wide analysis of estrogen receptor binding sites. Nat Genet. 2006;38:1289–1297
33. Handel AE, Sandve GK, Disanto G, et al. Integrating multiple oestrogen receptor ChIP studies: overlap with disease susceptibility regions, DNase I hypersensitivity peaks and gene expression. BMC Med Genomics. 2013;6:45.
34. Galien R, Garcia T. Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kB site. Nucleic Acids Res. 1997;25:2424–2429
35. Ghisletti S, Meda C, Maggi A, Vegeto E. 17b-Estradiol inhibits inflammatory gene expression by controlling NF-kB intracellular localization. Mol Cell Biol. 2005;25:2957–2968
36. Cvoro A, Tzagarakis-Foster C, Tatomer D, et al. Distinct roles of unliganded and liganded estrogen receptors in transcriptional repression. Mol Cell. 2006;21:555–564
37. Elsharkawy AM, Oakley F, Lin F, et al. The NF-kB p50:p50: HDAC-1 repressor complex orchestrates transcriptional inhibition of multiple pro-inflammatory genes. J Hepatol. 2010;53:519–527
38. Kobayashi K, Arimura Y, Goto A, et al. Therapeutic implications of the specific inhibition of causative matrix metalloproteinases in experimental colitis induced by dextran sulphate sodium. J Pathol. 2006;209:376–383
39. Lee SJ, Seo KW, Yun MR, et al. 4-Hydroxynonenal enhances MMP-2 production in vascular smooth muscle cells via mitochondrial ROS-mediated activation of the Akt/NF-kB signaling pathways. Free Radic Biol Med. 2008;45:1487–1492
40. Nettles KW, Gil G, Nowak J, et al. CBP Is a dosage-dependent regulator of nuclear factor suppression by the estrogen receptor. Mol Endocrinol. 2008;22:263-272.
41. Murray MY, Birkland TP, Howe JD, et al. Macrophage migration and invasion is regulated by MMP10 expression. PLoS One. 2013; 8:e63555
42. O’Kane CM, Elkington PT, Jones MD, et al. STAT3, p38 MAPK, and NF-kB drive unopposed monocyte-dependent fibroblast MMP-1 secretion in tuberculosis. Am J Respir Cell Mol Biol. 2010; 43:465–474
43. Ray P, Ghosh SK, Zhang DH, Ray A. Repression of interleukin-6 gene expression by 17b-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kB by the estrogen receptor. FEBS Lett. 1997;409:79–85
44. Rhee JW, Lee KW, Kim D, et al. NF-kB-dependent regulation of matrix metalloproteinase-9 gene expression by lipopolysaccharide in a macrophage cell line RAW 264.7. J Biochem Mol Biol. 2007; 40:88–94
45. Suzuki Y, Nagai N, Yamakawa K, et al. Tissue-type plasminogen activator (t-PA) induces stromelysin-1 (MMP-3) in endothelial cells through activation of lipoprotein receptor-related protein. Blood. 2009;114:3352–3358
46. Hao H, d’Alincourt-Salazar M, Kelley KM, et al. Estrogen-induced and TAFII30-mediated gene repression by direct recruitment of the estrogen receptor and co-repressors to the core promoter and its reversal by tamoxifen. Oncogene. 2007;26:7872–7884
47. Higgins KJ, Liu S, Abdelrahim M, et al. Vascular endothelial growth factor receptor-2 expression is down-regulated by 17b-estradiol in MCF-7 breast cancer cells by estrogen receptor k/Sp proteins. Mol Endocrinol. 2008;22:388–402
48. Konduri SD, Medisetty R, Liu W, et al. Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation. Proc Natl Acad Sci USA. 2010;107:15081–15086
49. Suzuki A, Sanda N, Miyawaki Y, et al. Down-regulation of PROS1 gene expression by 17[1]-estradiol via estrogen receptor b (ERk)-Sp1 interaction recruiting receptor-interacting protein 140 and the corepressor- HDAC3 complex. J Biol Chem. 2010;285:13444–13453
50. Nicholson RI, Gee JM, Manning DL, et al. Responses to pure antiestrogens (ICI 164384, ICI 182780) in estrogen-sensitive and -resistant experimental and clinical breast cancer. Ann NY Acad Sci. 1995;761:148–163
51. Lee JY, Choi HY, Ahn HJ, Ju BG, Yune TY. Matrix metalloproteinase- 3 promotes early blood-spinal cord barrier disruption and hemorrhage and impairs long-term neurological recovery after spinal cord injury. Am J Pathol. 2014;184:2985–3000
52. Rosenberg GA, Yang Y. Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia. Neurosurg Focus. 2007;22:E4
53. Kurzepa J, Kurzepa J, Golab P, Czerska S, Bielewicz J. The significance of matrix metalloproteinase (MMP)-2 and MMP-9 in the ischemic stroke. Int J Neurosci. 2014;124:707–716
54. Cuadrado E, Rosell A, Penalba A, et al. Vascular MMP-9/TIMP-2 and neuronal MMP-10 up-regulation in human brain after stroke: a combined laser microdissection and protein array study. J Proteome Res. 2009;8:3191–3197
55. Lenglet S, Montecucco F, Mach F, et al. Analysis of the expression of nine secreted matrix metalloproteinases and their endogenous inhibitors in the brain of mice subjected to ischaemic stroke. Thromb Haemost. 2014;112:363–378
56. Zhou Y, Cui Z, Xia X, et al. Matrix metalloproteinase-1 (MMP-1) expression in rat spinal cord injury model. Cell Mol Neurobiol. 2014;34:1151–1163
57. Grab DJ, Perides G, Dumler JS, et al. Borrelia burgdorferi, hostderived proteases, and the blood-brain barrier. Infect Immun. 2005;73:1014–1022
58. Roe K, Kumar M, Lum S, et al. West Nile virus-induced disruption of the blood-brain barrier in mice is characterized by the degradation of the junctional complex proteins and increase in multiple matrix metalloproteinases. J Gen Virol. 2012;93:1193–1203
59. Yang Y, Estrada EY, Thompson JF, Liu W, Rosenberg GA. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab. 2007; 27:697–709
60. Liu J, Jin X, Liu KJ, Liu W. Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage. J Neurosci. 2012;32:3044–3057
61. Yang J, Wang G, Gao C, Shao G, Kang N. Effects of hyperbaric oxygen on MMP-2 and MMP-9 expressions and spinal cord edema after spinal cord injury. Life Sci. 2013;93:1033–1038
62. Lee JY, Kim HS, Choi HY, OH TH, Yune TY. Fluoxetine inhibits matrix metalloprotease activation and prevents disruption of blood-spinal cord barrier after spinal cord injury. Brain. 2012;135: 2375–2389
63. Suofu Y, Clark JF, Broderick JP, et al. Matrix metalloproteinase-2 or -9 deletions protect against hemorrhagic transformation during early stage of cerebral ischemia and reperfusion. Neuroscience. 2012;212:180–189
64. Gurney KJ, Estrada EY, Rosenberg GA. Blood-brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation. Neurobiol Dis. 2006;23:87–96
65. Johnson JL, Dwivedi A, Somerville M, George SJ, Newby AC. Matrix metalloproteinase (MMP)-3 activates MMP-9 mediated vascular smooth muscle cell migration and neointima formation in mice. Arterioscler Thromb Vasc Biol. 2011;31:e35–e44
66. Justicia C, Panés J, Solé S, et al. Neutrophil infiltration increases matrix metalloproteinase-9 in the ischemic brain after occlusion/ reperfusion of the middle cerebral artery in rats. J Cereb Blood Flow Metab. 2003;23:1430–1440
67. McColl BW, Rothwell NJ, Allan SM. Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. J Neurosci. 2008;28:9451–9462
68. Jin R, Yang G, Li G. Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator. Neurobiol Dis. 2010;38:376–385
69. Asahi M, Wang X, Mori T, et al. Effects of matrix metalloproteinase- 9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci. 2001; 21:7724–7732
70. Higashida T, Kreipke CW, Rafols JA, et al. The role of hypoxiainducible factor-1k, aquaporin-4, and matrix metalloproteinase-9 in blood-brain barrier disruption and brain edema after traumatic brain injury. J Neurosurg. 2011;114:92–101
71. Woollard SM, Bhargavan B, Yu F, Kanmogne GD. Differential effects of Tat proteins derived from HIV-1 subtypes B and recombinant CRF02_AG on human brain microvascular endothelial cells: implications for blood-brain barrier dysfunction. J Cereb Blood Flow Metab. 2014;34:1047–1059
72. Saunders WB, Bayless KJ, Davis GE. MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices. J Cell Sci. 2005; 118:2325–2340
73. Ueno M, Wu B, Nishiyama A, et al. The expression of matrix metalloproteinase-13 is increased in vessels with blood-brain barrier impairment in a stroke-prone hypertensive model. Hypertens Res. 2009;32:332–338
74. Lu DY, Yu WH, Yeh WL, et al. Hypoxia-induced matrix metalloproteinase- 13 expression in astrocytes enhances permeability of brain endothelial cells. J Cell Physiol. 2009;220:163–173
75. Stirone C, Duckles SP, Krause DN. Multiple forms of estrogen receptor-k in cerebral blood vessels: regulation by estrogen. Am J Physiol Endocrinol Metab. 2003;284:E184–E192
76. Tu J, Jufri NF. Estrogen signaling through estrogen receptor b and G-protein-coupled estrogen receptor 1 in human cerebral vascular endothelial cells: implications for cerebral aneurysms. Biomed Res Int. 2013;2013:524324
77. Dubal DB, Zhu H, Yu J, et al. Estrogen receptor a not b, is a critical link in estradiol-mediated protection against brain injury. Proc Natl Acad Sci USA. 2001;98:1952–1957
78. Burek M, Arias-Loza PA, Roewer N, Förster CY. Claudin-5 as a novel estrogen target in vascular endothelium. Arterioscler Thromb Vasc Biol. 2010;30:298–304
79. An J, Ribeiro RC, Webb P, et al. Estradiol repression of tumor necrosis factor-a transcription requires estrogen receptor activation function-2 and is enhanced by coactivators. Proc Natl Acad Sci USA. 1999;96:15161–15166
80. Kim MY, Koh DI, Choi WI, et al. ZBTB2 increases PDK4 expression by transcriptional repression of RelA/p65. Nucleic Acids Res. 2015;43:1609–1625
81. Kielland A, Camassa LM, Døhlen G, et al. NF-kB activity in perinatal brain during infectious and hypoxic-ischemic insults revealed by a reporter mouse. Brain Pathol. 2012;22:499–510
82. Trickler WJ, Mayhan WG, Miller DW. Brain microvessel endothelial cell responses to tumor necrosis factor-a involve a nuclear factor kB (NF-kB) signal transduction pathway. Brain Res. 2005;1048: 24–31
83. Aslam M, Ahmad N, Srivastava R, Hemmer B. TNF-k induced NFkB signaling and p65 (RelA) overexpression repress Cldn5 promoter in mouse brain endothelial cells. Cytokine. 2012;57:269–275.